Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARTIST-CKD: Survodutide in CKD
NCT07206290Phase 2Not yet recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Mar 2026
- Primary completion
- Nov 2027
- Modality
- Peptides
01
Overview
A Phase 2 trial of survodutide in chronic kidney disease (CKD), sponsored by University Medical Center Groningen. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT07206290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07206290.